Model Number STQ4-RCV-A0, STQ4-SPR-B0 |
Device Problem
Improper or Incorrect Procedure or Method (2017)
|
Patient Problem
No Clinical Signs, Symptoms or Conditions (4582)
|
Event Date 01/26/2024 |
Event Type
Injury
|
Manufacturer Narrative
|
The other adverse events issues questionnaire was reviewed for potential causes of the reported issue.Based on this review, implanting the device at an off-label location has been ruled out as a potential cause.Potential causes of the reported issue are severe force applied to implant, severe force or bending during implantation, improper surgical technique, manufacturing issue, excessive pressure on the electrode array, and using incorrect tools at the time of the implant.However, the neurostimulator was fractured while attempting to explant the device.The stimulator is used to treat pain.The cause of the fractured lead is due to incorrect surgical technique as the neurostimultor was fractured during the explant procedure (user error - clinician).Rates reviewed at the most recent complaint trending meeting do not indicate a significant increase in other adverse events issues.Other adverse events issues rates remain acceptably low; thus, a capa is not required.Other adverse events issues rates will continue to be tracked and trended.
|
|
Event Description
|
As of (b)(6) 2020 the patient was receiving adequate therapy and the devices were helping with ilioinguinal and low back pain.On january 26, 2024, support received a call regarding mri clearance.An explant procedure was performed on (b)(6) 2020 where one neurostimulator was completely removed and the other was partially removed as it was fractured while attempting to explant.The reason for the explant procedure is unknown and there are no plans to remove the remaining portion.Additionally, it is unknown which device remains partially implanted.The surgeon noted the remaining portion of the neurostimulator is in the muscle tissue and since it isn't causing damage, harm, or risk, they didn't advise the patient to have it removed.
|
|
Manufacturer Narrative
|
The other adverse events issues questionnaire was reviewed for potential causes of the reported issue.Based on this review, implanting the device at an off-label location has been ruled out as a potential cause.Potential causes of the reported issue are severe force applied to implant, severe force or bending during implantation, improper surgical technique, manufacturing issue, excessive pressure on the electrode array, and using incorrect tools at the time of the implant.However, the neurostimulator was fractured while attempting to explant the device.The stimulator is used to treat pain.The cause of the fractured lead is due to incorrect surgical technique as the neurostimultor was fractured during the explant procedure (user error - clinician).Rates reviewed at the most recent complaint trending meeting do not indicate a significant increase in other adverse events issues.Other adverse events issues rates remain acceptably low; thus, a capa is not required.Other adverse events issues rates will continue to be tracked and trended.
|
|
Event Description
|
As of (b)(6) 2020 the patient was receiving adequate therapy and the devices were helping with ilioinguinal and low back pain.On (b)(6) 2024, support received a call regarding mri clearance.An explant procedure was performed on (b)(6) 2020 where one neurostimulator was completely removed and the other was partially removed as it was fractured while attempting to explant.The reason for the explant procedure is unknown and there are no plans to remove the remaining portion.Additionally, it is unknown which device remains partially implanted.The surgeon noted the remaining portion of the neurostimulator is in the muscle tissue and since it isn't causing damage, harm, or risk, they didn't advise the patient to have it removed.
|
|
Search Alerts/Recalls
|
|